26 participants
A Phase 2 Study of Lenalidomide in Patients With Relapsed or Recurrent Adult T-cell Leukemia-lymphoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2018-05-29
- Start Date:
- 2012-11-12
- Completion:
- 2014-11-20
Conditions
- Adult T-Cell Leukemia-Lymphoma
Interventions
- DRUG